Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, March 6, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Anupam Rama Maintained (APLS) at Buy with Increased Target to $79 on, Mar 6th, 2024
Anupam Rama of JP Morgan, Maintained "Apellis Pharmaceuticals, Inc." (APLS) at Buy with Increased Target from $78 to $79 on, Mar 6th, 2024.
Anupam has made no other calls on APLS in the last 4 months.
There are 13 other peers that have a rating on APLS. Out of the 13 peers that are also analyzing APLS, 3 agree with Anupam's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Laura Chico of "Wedbush" Maintained at Hold with Increased Target to $67 on, Wednesday, February 28th, 2024
- Graig Suvannavejh of "Mizuho" Maintained at Hold with Increased Target to $60 on, Friday, February 16th, 2024
- Derek Archila of "Wells Fargo" Downgraded from Buy to Hold and Decreased Target to $54 on, Thursday, December 14th, 2023
These are the ratings of the 10 analyists that currently disagree with Anupam
- Eliana Merle of "UBS" Maintained at Strong Buy with Increased Target to $89 on, Monday, March 4th, 2024
- Douglas Tsao of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $92 on, Wednesday, February 28th, 2024
- Colleen Kusy of "Baird" Reiterated at Buy and Held Target at $81 on, Tuesday, February 6th, 2024
- Akash Tewari of "Jefferies" Upgraded from Hold to Strong Buy and Increased Target to $80 on, Monday, February 5th, 2024
- Justin Kim of "Oppenheimer" Maintained at Buy with Increased Target to $79 on, Tuesday, January 30th, 2024
- Joseph Stringer of "Needham" Maintained at Strong Buy with Increased Target to $75 on, Wednesday, January 24th, 2024
- Steven Seedhouse of "Raymond James" Maintained at Strong Buy with Increased Target to $106 on, Thursday, January 11th, 2024
- Salveen Richter of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $90 on, Tuesday, January 9th, 2024
- Yigal Nochomovitz of "Citigroup" Maintained at Strong Buy with Decreased Target to $67 on, Friday, December 15th, 2023
- Tazeen Ahmad of "B of A Securities" Upgraded from Hold to Strong Buy and Increased Target to $85 on, Tuesday, December 5th, 2023
